Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center

Publication date: August 2022Source: Leukemia Research, Volume 119Author(s): Tamer Othman, Benjamin N. Moskoff, Gwendolyn Ho, Matthew E. Tenold, Tali Azenkot, Margaret L. Krackeler, Samantha C. Fisch, Laura A. Potter, Paul R. Kaesberg, Jeanna L. Welbor…